How Human Embryonic Stem Cells Sparked a Revolution
The human embryonic stem cells are obtained from the undifferentiated inner mass cell of the human embryo and human fetal tissue. The human embryonic stem cell can replicate indefinitely and produce non-regenerative tissue such as myocardial and neural cells. This potential of human embryonic stem cell allows them to provide an unlimited amount of tissue for transplantation therapies to treat a wide range of degenerative diseases. Hence, human embryonic stem cells are used in the treatment of various diseases such as Alzheimer's disease, cancer, blood and genetic disorders related to the immune system and others. Download PDF Brochure @ Click Here !!! Top Dominating Key Players : BD Takara Bio Inc. Geron Thermo Fisher Scientific Inc. ViaCyte, Inc. R&D Systems, Inc. QIAGEN CellGenix GmbH Vitrolife Lonza The global human embryonic stem cell market is expected to grow in upcoming years, factors driving the growth of market are rise in incidences of